» Articles » PMID: 6279341

Specific in Vitro Antibody Response to Varicella Zoster

Overview
Date 1981 Oct 1
PMID 6279341
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral blood mononuclear cells from normal donors were stimulated in vitro by varicella zoster (VZ) antigen and antibody measured by an ELISA technique. Antibody was produced in 14 of 19 individuals. This antibody was specific for VZ with no binding to herpes simplex virus (HSV), even when the mononuclear cells were taken from individuals who had circulating antibody to VZ and HSV. The failure of antibody production in mononuclear cell cultures from some normals, all of whom had serum antibody, was analysed using reciprocal combinations of E+ and E- cells from producers and non-producers. E+ cells from producers could help E- producer cells make antibody, but E+ cells from non-producers could not help E- cells from non-producers to do so. This result suggests a deficiency in circulating E- cells in non-producers. Four of four patients with untreated Hodgkin's disease were non-producers using blood mononuclear cell cultures, but their spleen cells produced antibody readily. This suggests that failure of in vitro antibody production in immune individuals may be due to sequestration of responsive B cells in spleen and other sites. This technique allows further study of the mechanisms of immunity to VZ in normal and immune-compromised individuals.

Citing Articles

Defective B cell function in systemic lupus erythematosus.

Pelton B, DENMAN A Clin Exp Immunol. 1982; 48(3):513-8.

PMID: 6981471 PMC: 1536611.


Intrathecal antibody synthesis to virus antigens in multiple sclerosis.

Salmi A, Reunanen M, Ilonen J, Panelius M Clin Exp Immunol. 1983; 52(2):241-9.

PMID: 6407791 PMC: 1535858.


In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.

Cupps T, Gerin J, Purcell R, Goldsmith P, Fauci A J Clin Invest. 1984; 74(4):1204-13.

PMID: 6332826 PMC: 425286. DOI: 10.1172/JCI111529.


Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.

Souhami R, Babbage J, Sigfusson A Clin Exp Immunol. 1983; 53(2):297-307.

PMID: 6309443 PMC: 1535670.


Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.

Akbar A, Jones D, Wright D Br J Cancer. 1984; 49(3):349-56.

PMID: 6231045 PMC: 1976757. DOI: 10.1038/bjc.1984.55.


References
1.
Brunell P, Ross A, MILLER L, Kuo B . Prevention of varicella by zoster immune globulin. N Engl J Med. 1969; 280(22):1191-4. DOI: 10.1056/NEJM196905292802201. View

2.
Armstrong R, Gurwith M, Waddell D, Merigan T . Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia. N Engl J Med. 1970; 283(22):1182-7. DOI: 10.1056/NEJM197011262832202. View

3.
MILLER L, Brunell P . Zoster, reinfection or activation of latent virus? Observations on the antibody response. Am J Med. 1970; 49(4):480-3. DOI: 10.1016/s0002-9343(70)80042-0. View

4.
Goffinet D, Glatstein E, Merigan T . Herpes Zoster-Varicella infections and lymphoma. Ann Intern Med. 1972; 76(2):235-40. DOI: 10.7326/0003-4819-76-2-235. View

5.
Callard R, Smith C . Histocompatibility requirements for T cell help in specific in vitro antibody responses to influenza virus by human blood lymphocytes. Eur J Immunol. 1981; 11(3):206-12. DOI: 10.1002/eji.1830110309. View